UTMB launches feasibility study of new device used during lumpectomy procedures
The University of Texas Medical Branch (UTMB) is enrolling patients in a U.S. feasibility study evaluating the investigational SIRA radiofrequency
Committed to innovative surgical solutions
The University of Texas Medical Branch (UTMB) is enrolling patients in a U.S. feasibility study evaluating the investigational SIRA radiofrequency
CHICAGO, March 3, 2026 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer,
CHICAGO, April 10, 2025 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative),
CHICAGO, Sept. 4, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, including
CHICAGO, April 9, 2019 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-energy surgical solutions, announced